Literature DB >> 15309594

[Review of cannabinoids in the treatment of nausea and vomiting].

L Radbruch1, F Nauck.   

Abstract

Cannabinoids are used to treat nausea and vomiting. The effect appears to be mediated by cannabinoid receptors in the nucleus tractus solitarius. Results are available from studies on the use of cannabinoids to manage nausea and vomiting after chemotherapy. None of these studies, however, compared cannabinoids with the newer serotonin antagonists. The antiemetic efficacy of cannabinoids for other indications has not yet been studied sufficiently. Most of the studies report significantly more or stronger side effects with cannabinoid medication in comparison to similar medication. In some of the studies on treatment after chemotherapy or radiotherapy, the patients terminated the cannabinoid therapy more frequently due to side effects. Although clinical studies have provided clear evidence for the antiemetic efficacy of cannabinoids, the frequency and severity of side effects argue against their use as the method of first choice. For patients who cannot be adequately treated with conventional antiemetic agents, cannabinoids can represent a valuable adjunct to the antiemetic regimen.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309594     DOI: 10.1007/s00482-004-0315-5

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  41 in total

1.  Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients.

Authors:  M Levitt
Journal:  Cancer Treat Rev       Date:  1982-12       Impact factor: 12.111

2.  Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol.

Authors:  R J Gralla; L B Tyson; L A Bordin; R A Clark; D P Kelsen; M G Kris; L B Kalman; S Groshen
Journal:  Cancer Treat Rep       Date:  1984-01

3.  Marijuana as antiemetic medicine: a survey of oncologists' experiences and attitudes.

Authors:  R E Doblin; M A Kleiman
Journal:  J Clin Oncol       Date:  1991-07       Impact factor: 44.544

4.  Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double blind study.

Authors:  S M Crawford; R Buckman
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

5.  Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis.

Authors:  M Pomeroy; J J Fennelly; M Towers
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.

Authors:  L E Orr; J F McKernan; B Bloome
Journal:  Arch Intern Med       Date:  1980-11

7.  Marijuana as an antiemetic drug: how useful is it today? Opinions from clinical oncologists.

Authors:  R H Schwartz; R A Beveridge
Journal:  J Addict Dis       Date:  1994

8.  Comparative trial of the antiemetic effects of THC and haloperidol.

Authors:  J A Neidhart; M M Gagen; H E Wilson; D C Young
Journal:  J Clin Pharmacol       Date:  1981 Aug-Sep       Impact factor: 3.126

9.  A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.

Authors:  A E Chang; D J Shiling; R C Stillman; N H Goldberg; C A Seipp; I Barofsky; S A Rosenberg
Journal:  Cancer       Date:  1981-04-01       Impact factor: 6.860

10.  Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.

Authors:  S Frytak; C G Moertel; J R O'Fallon; J Rubin; E T Creagan; M J O'Connell; A J Schutt; N W Schwartau
Journal:  Ann Intern Med       Date:  1979-12       Impact factor: 25.391

View more
  1 in total

1.  [Cannabinoids in medicine].

Authors:  Rita Lenk; Rudolf Likar
Journal:  Wien Med Wochenschr       Date:  2008
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.